E5564
Phase 1Terminated 0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedAbout E5564
E5564 is a phase 1 stage product being developed by Eisai for Leukemia. The current trial status is terminated. This product is registered under clinical trial identifier NCT00756912. Target conditions include Leukemia.
What happened to similar drugs?
20 of 20 similar drugs in Leukemia were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
6
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00756912 | Phase 1 | Terminated |
| NCT00046072 | Phase 2 | Completed |
Competing Products
20 competing products in Leukemia